Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Author
Haviland, J
Sydenham, M
Hopwood, P
Kirby, A
Somaiah, N
Stones, L
Bliss, J
Yarnold, J
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Clinical Trials & Statistics Unit
Breast Cancer Radiotherapy
Translational Breast Radiobiology
Language
eng
Date accepted
2020-04-09
License start date
2020-04-09
Citation
The Lancet
Publisher
Elsevier